A
DCPH

AJOVista’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

AJOVista’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,695
Closed -$75.7K – 449
2023
Q4 		$75.7K Buy
+4,695
New +$59.9K 0.1% 212

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

AJOVista's DCPH Position: Q1 2024 in Review

AJOVista sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 4,695 shares — an estimated $75.7K sold.

AJOVista first reported a position in DCPH in Q4 2023 and held it in 1 quarter. The position peaked at $75.7K in Q4 2023. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • AJOVista reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • AJOVista sold 4,695 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $75.7K.
  • AJOVista first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • AJOVista's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $75.7K in Q4 2023.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.